Literature DB >> 33303068

Impact of Plaque Burden Versus Stenosis on Ischemic Events in Patients With Coronary Atherosclerosis.

Martin Bødtker Mortensen1, Omar Dzaye2, Flemming Hald Steffensen3, Hans Erik Bøtker4, Jesper Møller Jensen4, Niels Peter Rønnow Sand5, Kristian Hay Kragholm6, Henrik Toft Sørensen7, Jonathon Leipsic8, Michael Mæng4, Michael J Blaha2, Bjarne Linde Nørgaard4.   

Abstract

BACKGROUND: Patients with obstructive coronary artery disease (CAD) are at high risk for cardiovascular disease (CVD) events. However, it remains unclear whether the high risk is due to high atherosclerotic disease burden or if presence of stenosis has independent predictive value.
OBJECTIVES: The purpose of this study was to evaluate if obstructive CAD provides predictive value beyond its association with total calcified atherosclerotic plaque burden as assessed by coronary artery calcium (CAC).
METHODS: Among 23,759 symptomatic patients from the Western Denmark Heart Registry who underwent diagnostic computed tomography angiography (CTA), we assessed the risk of major CVD (myocardial infarction, stroke, and all-cause death) stratified by CAC burden and number of vessels with obstructive disease.
RESULTS: During a median follow-up of 4.3 years, 1,054 patients experienced a first major CVD event. The event rate increased stepwise with both higher CAC scores and number of vessels with obstructive disease (by CAC scores: 6.2 per 1,000 person-years (PY) for CAC = 0 to 42.3 per 1,000 PY for CAC >1,000; by number of vessels with obstructive disease: 6.1 per 1,000 PY for no CAD to 34.7 per 1,000 PY for 3-vessel disease). When stratified by 5 groups of CAC scores (0, 1 to 99, 100 to 399, 400 to 1,000, and >1,000), the presence of obstructive CAD was not associated with higher risk than presence of nonobstructive CAD.
CONCLUSIONS: Plaque burden, not stenosis per se, is the main predictor of risk for CVD events and death. Thus, patients with a comparable calcified atherosclerosis burden generally carry a similar risk for CVD events regardless of whether they have nonobstructive or obstructive CAD.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cardiovascular disease risk; cohort study; computed tomography angiography; coronary artery calcium; coronary artery disease; epidemiology; obstructive vessel disease

Mesh:

Year:  2020        PMID: 33303068     DOI: 10.1016/j.jacc.2020.10.021

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  20 in total

1.  ASNC's thoughts on the AHA/ACC chest pain guidelines.

Authors:  Randall C Thompson; Mouaz H Al-Mallah; Rob S B Beanlands; Dennis A Calnon; Sharmila Dorbala; Lawrence M Phillips; Donna M Polk; Prem Soman
Journal:  J Nucl Cardiol       Date:  2021-11-15       Impact factor: 5.952

Review 2.  2021 Update for the Diagnosis and Management of Acute Coronary Syndromes for the Perioperative Clinician.

Authors:  Katherine J Kunkel; Alejandro Lemor; Shazil Mahmood; Pedro Villablanca; Harish Ramakrishna
Journal:  J Cardiothorac Vasc Anesth       Date:  2021-07-22       Impact factor: 2.894

3.  The impact of coronary calcium score as an addition to myocardial perfusion imaging in altering clinical management (ICCAMPA trial).

Authors:  Pavithra S Jayadeva; Stephen Stowers; E W Tang; Joao Vitola; Rodrigo Cerci; Jessica Yao; James Westcott; Barry Elison; Nathan Better
Journal:  J Nucl Cardiol       Date:  2022-09-12       Impact factor: 3.872

4.  Preventive cardiology advances in the 2021 AHA/ACC chest pain guideline.

Authors:  Rhanderson Cardoso; Leslee J Shaw; Roger S Blumenthal; Khurram Nasir; Richard Ferraro; David J Maron; Michael J Blaha; Martha Gulati; Deepak L Bhatt; Ron Blankstein
Journal:  Am J Prev Cardiol       Date:  2022-06-30

5.  Coronary artery calcium scores indicating secondary prevention level risk: Findings from the CAC consortium and FOURIER trial.

Authors:  Omar Dzaye; Alexander C Razavi; Erin D Michos; Martin Bødtker Mortensen; Zeina A Dardari; Khurram Nasir; Albert D Osei; Allison W Peng; Ron Blankstein; John H Page; Michael J Blaha
Journal:  Atherosclerosis       Date:  2022-02-12       Impact factor: 6.847

Review 6.  Evaluation of coronary stenosis versus plaque burden for atherosclerotic cardiovascular disease risk assessment and management.

Authors:  Omar Dzaye; Alexander C Razavi; Michael J Blaha; Martin Bødtker Mortensen
Journal:  Curr Opin Cardiol       Date:  2021-11-01       Impact factor: 2.108

7.  Coronary Artery Calcium for Risk Stratification of Sudden Cardiac Death: The Coronary Artery Calcium Consortium.

Authors:  Alexander C Razavi; S M Iftekhar Uddin; Zeina A Dardari; Daniel S Berman; Matthew J Budoff; Michael D Miedema; Albert D Osei; Olufunmilayo H Obisesan; Khurram Nasir; Alan Rozanski; John A Rumberger; Leslee J Shaw; Laurence S Sperling; Seamus P Whelton; Martin Bødtker Mortensen; Michael J Blaha; Omar Dzaye
Journal:  JACC Cardiovasc Imaging       Date:  2022-03-21

8.  Histopathology-Based Deep-Learning Predicts Atherosclerotic Lesions in Intravascular Imaging.

Authors:  Olle Holmberg; Tobias Lenz; Valentin Koch; Aseel Alyagoob; Léa Utsch; Andreas Rank; Emina Sabic; Masaru Seguchi; Erion Xhepa; Sebastian Kufner; Salvatore Cassese; Adnan Kastrati; Carsten Marr; Michael Joner; Philipp Nicol
Journal:  Front Cardiovasc Med       Date:  2021-12-14

Review 9.  Functional Angioplasty: Definitions, Historical Overview, and Future Perspectives.

Authors:  Hanbit Park; Do-Yoon Kang; Cheol Whan Lee
Journal:  Korean Circ J       Date:  2022-01       Impact factor: 3.243

10.  Prognosis of Coronary Atherosclerotic Burden in Non-Ischemic Dilated Cardiomyopathies.

Authors:  Marjorie Canu; Léa Margerit; Ismail Mekhdoul; Alexis Broisat; Laurent Riou; Loïc Djaileb; Clémence Charlon; Adrien Jankowski; Michele Magnesa; Caroline Augier; Stéphanie Marlière; Muriel Salvat; Charlotte Casset; Marion Maurin; Carole Saunier; Daniel Fagret; Catherine Ghezzi; Gerald Vanzetto; Gilles Barone-Rochette
Journal:  J Clin Med       Date:  2021-05-18       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.